Cardiac Electrophysiology and Arrhythmia Management (ISCEAM-26)

This track focuses on the latest advancements in cardiac electrophysiology technologies and methodologies. Contributions will explore novel diagnostic tools and therapeutic approaches that enhance patient outcomes in arrhythmia management.

This session will delve into the underlying mechanisms of various heart rhythm disorders, including atrial fibrillation and ventricular tachycardia. Presentations will highlight innovative management strategies and their clinical implications.

This track will cover the latest techniques in ablation therapy for arrhythmias, including radiofrequency and cryoablation. Participants will discuss clinical outcomes and patient selection criteria to optimize treatment efficacy.

This session will explore cutting-edge cardiac mapping technologies that enhance the precision of arrhythmia diagnosis and treatment. Emphasis will be placed on the integration of imaging modalities and their impact on procedural success.

This track will examine the evolving role of pacemakers and implantable cardioverter-defibrillators in managing arrhythmias. Discussions will include device innovations, programming strategies, and long-term patient management.

This session aims to highlight translational research in electrophysiology, focusing on how laboratory findings can inform clinical practice. Presenters will discuss ongoing studies and their potential to reshape arrhythmia management.

This track will address the integration of electrophysiology into broader clinical cardiology practices. Topics will include collaborative care models and the role of electrophysiologists in multidisciplinary teams.

This session will focus on the importance of patient-centered care in the management of arrhythmias. Presentations will explore shared decision-making, patient education, and the psychosocial aspects of living with heart rhythm disorders.

This track will review new pharmacological agents and their roles in the management of arrhythmias. Emphasis will be placed on clinical trial results and the implications for practice.

This session will explore the genetic basis of inherited arrhythmia syndromes and their implications for diagnosis and treatment. Presentations will discuss advancements in genetic testing and personalized medicine approaches.

This track will provide a platform for discussing future research directions in cardiac electrophysiology. Participants will share innovative ideas and potential collaborations aimed at addressing current challenges in arrhythmia management.